Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

Epilepsy Research

Volumn 2, Issue 3, 1988, Pages 145-181

  Löscher, Wolfgang ^a   Schmidt, Dieter ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Animal models; Antiepileptic drugs

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; DENZIMOL; ETEROBARB; ETHOSUXIMIDE; FLUNARIZINE; FLUPIRTINE; GABOXADOL; LAMOTRIGINE; MILACEMIDE; NAFIMIDONE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROGABIDE; TRIMETHADIONE; VALPROIC ACID; ZONISAMIDE;

ANIMAL MODEL; DRUG THERAPY; EPILEPTOGENESIS; HUMAN; NONHUMAN; REVIEW;

ANIMAL; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY;

EID: 0023897574     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(88)90054-X     Document Type: Review

References (192)

1. Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats
2. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat
3. Experimental models of aging and quinolinic acid
4. Behavioral analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rats
5. Efficacy of baclofen and phenobarbital against the kainic acid limbic seizure-brain damage syndrome
6. Experimental anticonvulsive properties of GP 47 680 and of GP 47 779, its main human metabolite; compounds related to carbamazepine
7. Gabapentin
8. Une nouvelle méthode simple pour explorer l'action ‘tranquillisante’ le test de la cheminée
9. Nafimidone
10. Pharmacological modification of amygdaloid-kindled seizures
11. CM 40907 and SR 41378: two piperidino-pyridazine derivatives
12. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures
13. Audiogenic seizures
14. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
15. Proposal for classification of epilepsies and epileptic syndromes
16. Audiogenic seizure susceptible rats
17. A new device for the rapid measurement of impaired motor function in mice
18. Evidence for a role of neurotransmitters in the mechanism of topical convulsant models
19. Tissue culture models of epileptiform activity
20. A new mutant causing epileptic seizures in domestic fowls
21. A comparative study of progabide, valproate and placebo as add-on therapy in patients with refractory epilepsy
22. Anticonvulsant action of excitatory amino acid antagonists
23. Microiontophoretic studies of single neurons
24. Phosphonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in mice
25. GABA-agonists in the treatment of epilepsy
26. A note on a simple apparatus for detecting neurological deficit in rats and mice
27. Anticonvulsant properties of rozipine in epileptic and nonepileptic beagle dogs
28. Potential relevance of kindling to human partial epilepsy
29. Esquirol, 1815
30. The THIP-induced model of bilateral synchronous spike and wave in rodents
31. A double-blind, placebo controlled trial of progabide in epilepsy
32. The spontaneous seizure genotype sz in hamsters as a disease model of benzodiazepine receptor deficits
33. Primidone
34. Experimental evidence for the development of tolerance to anticonvulsant drug effects
35. Anticonvulsant potency of common antiepileptic drugs in the gerbil
36. Development of tolerance to the anticonvulsant effects of flunarizine and its side effects? Clinical, psychometric, EEG and biochemical approaches
37. Eterobarb
38. Relative frequency of different types of epilepsy: a study employing the classification of the International League Against Epilepsy
39. Antiepileptic drug development program
40. Experimental derangements of extracellular ionic environment
41. A permanent change in brain function resulting from daily electrical stimulation
42. Kindling and the forces that oppose it
43. Antagonism of gamma-hydroxybutyrate-induced hypersynchronization in the ECoG of the rat by anti-petit mal drugs
44. Epileptogenic action of some direct GABA agonists: effects of manipulation of the GABA and glutamate systems
45. Oxcarbazepine
46. Tottering — a neuromuscular mutation in the mouse
47. Gamma-vinyl GABA
48. Anticonvulsant sensitivity of absence seizures in the tottering mutant mouse
49. A simple intravenous infusion technique for mice
50. Qualitative and quantitative evaluation of experimentally induced seizures
51. Epilepsy: seizures and syndromes
52. Anticonvulsants in epileplic fowl
53. Hydantoins
54. Serum concentrations of phenytoin after oral administration in rats
55. Epidemiology of intractable epilepsy
56. Toleranz kleiner Laboratoriumstiere gegenüber intravenös injizierten Flüssigkeitsmengen und Einfluss des Injektionsvolumens auf einige Arzneimittelwirkungen
57. What triggers seizures in the gerbil, Meriones unguiculatus?
58. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologie, biochemical and histopathologic studies
59. Photomyoclonic seizures in the baboon
60. Mise en évidence chez certains singes d'un syndrome photomyoclonique
61. Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice
62. Spontaneous EEG paroxysms in the rat: effect of psychotropic and alpha-adrenergic agents
63. Animal experimental methods in the study of antiepileptic drugs
64. Antiepileptic drug development. II. Anticonvulsant drug screening
65. Chemistry and pharmacology of the GABA agonists THIP (gahoxadol) and isoguvacine
66. Anticonvulsant profile of lamotrigine. a novel anticonvulsant
67. A double-blind crossover evaluation of progabide in partial seizures
68. The production of epileptogenic cortical foci in experimental animals by freezing
69. CGS 9896: a pyrazoloquinoline with partial benzodiazepine agonist properties
70. A simplified method of evaluating dose-effect experiments
71. Optimizing the pentylenetetrazol infusion method for measuring seizure thresholds
72. Alterations of GABA-mediated synaptic transmission in human epilepsy
73. Comparative assay of anticonvulsant and toxic potencies of sixteen GABA-mimetic drugs
74. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice
75. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review
76. Valproic acid
77. GABA-mimetics in animal models of seizure states
78. Anticonvulsant action in the epileptic gerbil of novel inhibitors of GABA uptake
79. Anticonvulsant action of GABA agonists and prodrugs on minor and major seizures in epileptic gerbils. Comparison with mouse models of seizure states
80. Trarns-2-en-valproic acid
81. Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the Mongolian gerbil
82. Experimental models for intractable epilepsy in nonprimate animal species
83. Development of tolerance to the anticonvulsant effect of GABAmimetic drugs in genetically epilepsyprone gerbils
84. Pharmacokinetics of valproate in dog and mouse
85. Evaluation of anticonvulsant drugs in gerbils with reflex epilepsy
86. Evaluation of anticonvulsant drugs in genetic animal models of epilepsy
87. Evaluation of different GABA receptor agonists in the kindled amygdala seizure model in rats
88. Development of tolerance to the anticonvulsant effect of diazepam in amygdalakindled rats
89. AE mice: an inbred mouse strain with interesting features for epilepsy research
90. High anticonvulsant potency of γ-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy
91. Is amygdalakindling in rats a model for drug-resistant partial epilepsy?
92. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy
93. Evaluation of differentβ-carbolines in Mongolian gerbils with reflex epilepsy
94. Evaluation of epileptic dogs as an animal model of human epilepsy
95. Efficacité du valproate de sodium dans les epilepsies partielles. Etude croisée valproate-carbamazépine
96. The Mongolian gerbil (Meriones unguiculatus) as a model for the study of the epilepsies: EEG records of seizures
97. The gerbil as a model for the study of the epilepsies
98. Ionic conditions and membrane behaviour
99. Anticonvulsant drugs: mechanisms of action
100. Diazepam antagonizes GABAmimetics in rats with spontaneous petit mal-like epilepsy
101. Focal electrical stimulation
102. Kindling: an animal model of complex partial epilepsy
103. Electrical stimulation of specified subsystems of the mammalian brain, as isolated tissue preparations
104. Kindling mechanisms: current progress on an experimental epilepsy model
105. Convulsant drugs, anticonvulsants and GABA-mediated neuronal inhibition
106. Mechanism of action of valproate
107. GABA and other amino acids
108. Pharmacological approaches to the treatment of epilepsy
109. Benzodiazepine receptors and their relationship to the treatment of epilepsy
110. ZK 91296 and ZK 93423: β-carbolines with partial or full agonist activity at benzodiazepine receptors
111. Epileptogenic and anticonvulsant effects of GABA agonists and GABA uptake inhibitors
112. Effects of GABAmimetics and GABA antagonists on spontaneous nonconvulsive seizures in Wistar rats
113. Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat
114. Lamotrigine
115. Antiepileptic effect of the β-carbolines: preliminary single-dose studies of ZK 95962 in photosensitive epileptic patients
116. Progabide
117. Petit mal epilepsy: too little or too much GABA?
118. Effects of γ-acetylenic GABA and γ-vinyl GABA on metrazol-activated, and kindled seizures
119. Photogenic seizures in baboon
120. Valproic acid and metabolites: pharmacological and toxicological studies
121. Analysis of inherited epilepsy using single locus mutations in mice
122. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering
123. The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs
124. Felbamate
125. DMCM: a potent convulsive benzodiazepine receptor ligand
126. Chronic treatment with lorazepam and FG 7142 may change the effects of benzodiazepine receptor agonists, antagonists and inverse agonists by different mechanisms
127. Neurotransmitter and neuromodulator function in the kindled seizure and state
128. Electrode placement and kindling-induced experimental epilepsy
129. Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate
130. Topical convulsant drugs and metabolic antagonists
131. Centroencephalic spike and wave discharges following parenteral penicillin injection in the cat
132. Experimental determination of the anticonvulsant properties of some phenyl derivatives
133. Modification of seizure activity by electrical stimulation. II. Motor seizure
134. Milacemide
135. Vigabatrin
136. Adverse effects
137. Diagnostic and therapeutic management of intractable epilepsy
138. Progabide for refractory partial epilepsy: a controlled add-on trial
139. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine
140. Clinical development of benzodiazepines and other antiepileptic drugs for intractable epilepsy
141. Clobazam for refractory focal epilepsy. A controlled trial
142. Tolerance to the antiepileptic effect of clobazam
143. Prophylaxis of amygdala kindling-induced epileptogenesis: comparison of a GABA uptake inhibitor and diazepam
144. Comparison of the anticonvulsant effects of two novel GABA uptake inhibitors and diazepam in amygdaloid kindled rats
145. Flupirtine
146. Audiogenic seizures in mice
147. A review of mouse mutants as genetic models of epilepsy
148. Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats
149. Differential effect of ethosuximide and of electrical stimulation on inhibitory and excitatory mechanisms
150. Gamma-hydroxybutyric acid, gammaaminobutyric acid, and petit mal epilepsy
151. γ-Hydroxybutyric acid in subcellular fractions of rat brain
152. β-Carbolines with agonistic and inverse agonistic properties at benzodiazepine receptors of the rat
153. Systemic chemical convulsants and metabolic derangements
154. Experimentelle Erzeugung von Krampfen
155. Sensory precipitating epilepsy focus in El mice and Mongolian gerbils
156. Laboratory assay of clinically effective antiepileptic drugs
157. Electrically induced convulsions
158. Assay of antiepileptic drug activity in experimental animals: standard tests
159. Experimental detection, quantification, and evaluation of anticonvulsants
160. Comparative assays of antiepileptic drugs in mice and rats
161. Seizure control following administration of anticonvulsant drugs in the quaking mouse
162. Zonisamide
163. Denzimol
164. Spontaneous seizures in the Mongolian gerbil (Meriones unguiculatus)
165. Clobazam
166. MK-801
167. A comparison of phenytoin and valproate in previously untreated adult epileptic patients
168. Cholinomimetics produce seizures and brain damage in rats
169. Flunarizine
170. Anticonvulsant activity of milacemide
171. Two types of electrocortical paroxysms in an inbred strain of rats
172. Role of brain serotonin in myoclonus
173. Spontaneous paroxysmal electroclinical patterns in the rat: a model of generalized non-convulsive epilepsy
174. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid electroencephalographic behavioral and histological assessments
175. Stiripentol
176. Topical convulsant metals
177. Chronic focal epileptiform discharges induced by the injection of iron into rat and cat cortex
178. The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist
179. Applications to drug evaluations
180. Spontaneous seizures a new mutation in Syrian golden hamsters
181. Novel inhibitors of γ-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice